LARS1 and cancer: As the coupling effect of SNHG6 was investigated in cancer cells, cholesterol availability sensed by FAF2 was hypothesized to crosstalk with LARS1, which senses leucine availability, in turn activating mTORC1 for downstream signaling pathway activation in diseased states, such as cancer.